Global Gene Therapies for Tumor Treatment Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
LPI (LP Information)' newest research report, the “Gene Therapies for Tumor Treatment Industry Forecast” looks at past sales and reviews total world Gene Therapies for Tumor Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapies for Tumor Treatment sales for 2023 through 2029. With Gene Therapies for Tumor Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapies for Tumor Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapies for Tumor Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapies for Tumor Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gene Therapies for Tumor Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapies for Tumor Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapies for Tumor Treatment.
The global Gene Therapies for Tumor Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapies for Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapies for Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapies for Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapies for Tumor Treatment players cover Novartis, Kite Pharma, Amgen, Shanghai Sunway and Sibiono, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapies for Tumor Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Gene Therapies for Tumor Treatment market?
What factors are driving Gene Therapies for Tumor Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gene Therapies for Tumor Treatment market opportunities vary by end market size?
How does Gene Therapies for Tumor Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
LPI (LP Information)' newest research report, the “Gene Therapies for Tumor Treatment Industry Forecast” looks at past sales and reviews total world Gene Therapies for Tumor Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapies for Tumor Treatment sales for 2023 through 2029. With Gene Therapies for Tumor Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapies for Tumor Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapies for Tumor Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapies for Tumor Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gene Therapies for Tumor Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapies for Tumor Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapies for Tumor Treatment.
The global Gene Therapies for Tumor Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene Therapies for Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene Therapies for Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene Therapies for Tumor Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene Therapies for Tumor Treatment players cover Novartis, Kite Pharma, Amgen, Shanghai Sunway and Sibiono, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapies for Tumor Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Gene Induced Immunotherapy
- Oncolytic Virotherapy
- Gene Transfer
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Kite Pharma
- Amgen
- Shanghai Sunway
- Sibiono
What is the 10-year outlook for the global Gene Therapies for Tumor Treatment market?
What factors are driving Gene Therapies for Tumor Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gene Therapies for Tumor Treatment market opportunities vary by end market size?
How does Gene Therapies for Tumor Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapies for Tumor Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gene Therapies for Tumor Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gene Therapies for Tumor Treatment by Country/Region, 2018, 2022 & 2029
2.2 Gene Therapies for Tumor Treatment Segment by Type
2.2.1 Gene Induced Immunotherapy
2.2.2 Oncolytic Virotherapy
2.2.3 Gene Transfer
2.3 Gene Therapies for Tumor Treatment Sales by Type
2.3.1 Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Gene Therapies for Tumor Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gene Therapies for Tumor Treatment Sale Price by Type (2018-2023)
2.4 Gene Therapies for Tumor Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gene Therapies for Tumor Treatment Sales by Application
2.5.1 Global Gene Therapies for Tumor Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Gene Therapies for Tumor Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gene Therapies for Tumor Treatment Sale Price by Application (2018-2023)
3 GLOBAL GENE THERAPIES FOR TUMOR TREATMENT BY COMPANY
3.1 Global Gene Therapies for Tumor Treatment Breakdown Data by Company
3.1.1 Global Gene Therapies for Tumor Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Company (2018-2023)
3.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Gene Therapies for Tumor Treatment Revenue by Company (2018-2023)
3.2.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Gene Therapies for Tumor Treatment Sale Price by Company
3.4 Key Manufacturers Gene Therapies for Tumor Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gene Therapies for Tumor Treatment Product Location Distribution
3.4.2 Players Gene Therapies for Tumor Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENE THERAPIES FOR TUMOR TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Gene Therapies for Tumor Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Gene Therapies for Tumor Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gene Therapies for Tumor Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Gene Therapies for Tumor Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gene Therapies for Tumor Treatment Sales Growth
4.4 APAC Gene Therapies for Tumor Treatment Sales Growth
4.5 Europe Gene Therapies for Tumor Treatment Sales Growth
4.6 Middle East & Africa Gene Therapies for Tumor Treatment Sales Growth
5 AMERICAS
5.1 Americas Gene Therapies for Tumor Treatment Sales by Country
5.1.1 Americas Gene Therapies for Tumor Treatment Sales by Country (2018-2023)
5.1.2 Americas Gene Therapies for Tumor Treatment Revenue by Country (2018-2023)
5.2 Americas Gene Therapies for Tumor Treatment Sales by Type
5.3 Americas Gene Therapies for Tumor Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapies for Tumor Treatment Sales by Region
6.1.1 APAC Gene Therapies for Tumor Treatment Sales by Region (2018-2023)
6.1.2 APAC Gene Therapies for Tumor Treatment Revenue by Region (2018-2023)
6.2 APAC Gene Therapies for Tumor Treatment Sales by Type
6.3 APAC Gene Therapies for Tumor Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gene Therapies for Tumor Treatment by Country
7.1.1 Europe Gene Therapies for Tumor Treatment Sales by Country (2018-2023)
7.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Country (2018-2023)
7.2 Europe Gene Therapies for Tumor Treatment Sales by Type
7.3 Europe Gene Therapies for Tumor Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapies for Tumor Treatment by Country
8.1.1 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type
8.3 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gene Therapies for Tumor Treatment
10.3 Manufacturing Process Analysis of Gene Therapies for Tumor Treatment
10.4 Industry Chain Structure of Gene Therapies for Tumor Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gene Therapies for Tumor Treatment Distributors
11.3 Gene Therapies for Tumor Treatment Customer
12 WORLD FORECAST REVIEW FOR GENE THERAPIES FOR TUMOR TREATMENT BY GEOGRAPHIC REGION
12.1 Global Gene Therapies for Tumor Treatment Market Size Forecast by Region
12.1.1 Global Gene Therapies for Tumor Treatment Forecast by Region (2024-2029)
12.1.2 Global Gene Therapies for Tumor Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gene Therapies for Tumor Treatment Forecast by Type
12.7 Global Gene Therapies for Tumor Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.1.3 Novartis Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Kite Pharma
13.2.1 Kite Pharma Company Information
13.2.2 Kite Pharma Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Kite Pharma Main Business Overview
13.2.5 Kite Pharma Latest Developments
13.3 Amgen
13.3.1 Amgen Company Information
13.3.2 Amgen Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.3.3 Amgen Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Amgen Main Business Overview
13.3.5 Amgen Latest Developments
13.4 Shanghai Sunway
13.4.1 Shanghai Sunway Company Information
13.4.2 Shanghai Sunway Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shanghai Sunway Main Business Overview
13.4.5 Shanghai Sunway Latest Developments
13.5 Sibiono
13.5.1 Sibiono Company Information
13.5.2 Sibiono Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.5.3 Sibiono Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sibiono Main Business Overview
13.5.5 Sibiono Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapies for Tumor Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gene Therapies for Tumor Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gene Therapies for Tumor Treatment by Country/Region, 2018, 2022 & 2029
2.2 Gene Therapies for Tumor Treatment Segment by Type
2.2.1 Gene Induced Immunotherapy
2.2.2 Oncolytic Virotherapy
2.2.3 Gene Transfer
2.3 Gene Therapies for Tumor Treatment Sales by Type
2.3.1 Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Gene Therapies for Tumor Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gene Therapies for Tumor Treatment Sale Price by Type (2018-2023)
2.4 Gene Therapies for Tumor Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gene Therapies for Tumor Treatment Sales by Application
2.5.1 Global Gene Therapies for Tumor Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Gene Therapies for Tumor Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gene Therapies for Tumor Treatment Sale Price by Application (2018-2023)
3 GLOBAL GENE THERAPIES FOR TUMOR TREATMENT BY COMPANY
3.1 Global Gene Therapies for Tumor Treatment Breakdown Data by Company
3.1.1 Global Gene Therapies for Tumor Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Company (2018-2023)
3.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Gene Therapies for Tumor Treatment Revenue by Company (2018-2023)
3.2.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Gene Therapies for Tumor Treatment Sale Price by Company
3.4 Key Manufacturers Gene Therapies for Tumor Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gene Therapies for Tumor Treatment Product Location Distribution
3.4.2 Players Gene Therapies for Tumor Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENE THERAPIES FOR TUMOR TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Gene Therapies for Tumor Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Gene Therapies for Tumor Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gene Therapies for Tumor Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Gene Therapies for Tumor Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gene Therapies for Tumor Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gene Therapies for Tumor Treatment Sales Growth
4.4 APAC Gene Therapies for Tumor Treatment Sales Growth
4.5 Europe Gene Therapies for Tumor Treatment Sales Growth
4.6 Middle East & Africa Gene Therapies for Tumor Treatment Sales Growth
5 AMERICAS
5.1 Americas Gene Therapies for Tumor Treatment Sales by Country
5.1.1 Americas Gene Therapies for Tumor Treatment Sales by Country (2018-2023)
5.1.2 Americas Gene Therapies for Tumor Treatment Revenue by Country (2018-2023)
5.2 Americas Gene Therapies for Tumor Treatment Sales by Type
5.3 Americas Gene Therapies for Tumor Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapies for Tumor Treatment Sales by Region
6.1.1 APAC Gene Therapies for Tumor Treatment Sales by Region (2018-2023)
6.1.2 APAC Gene Therapies for Tumor Treatment Revenue by Region (2018-2023)
6.2 APAC Gene Therapies for Tumor Treatment Sales by Type
6.3 APAC Gene Therapies for Tumor Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gene Therapies for Tumor Treatment by Country
7.1.1 Europe Gene Therapies for Tumor Treatment Sales by Country (2018-2023)
7.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Country (2018-2023)
7.2 Europe Gene Therapies for Tumor Treatment Sales by Type
7.3 Europe Gene Therapies for Tumor Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapies for Tumor Treatment by Country
8.1.1 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type
8.3 Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gene Therapies for Tumor Treatment
10.3 Manufacturing Process Analysis of Gene Therapies for Tumor Treatment
10.4 Industry Chain Structure of Gene Therapies for Tumor Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gene Therapies for Tumor Treatment Distributors
11.3 Gene Therapies for Tumor Treatment Customer
12 WORLD FORECAST REVIEW FOR GENE THERAPIES FOR TUMOR TREATMENT BY GEOGRAPHIC REGION
12.1 Global Gene Therapies for Tumor Treatment Market Size Forecast by Region
12.1.1 Global Gene Therapies for Tumor Treatment Forecast by Region (2024-2029)
12.1.2 Global Gene Therapies for Tumor Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gene Therapies for Tumor Treatment Forecast by Type
12.7 Global Gene Therapies for Tumor Treatment Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.1.3 Novartis Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Kite Pharma
13.2.1 Kite Pharma Company Information
13.2.2 Kite Pharma Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Kite Pharma Main Business Overview
13.2.5 Kite Pharma Latest Developments
13.3 Amgen
13.3.1 Amgen Company Information
13.3.2 Amgen Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.3.3 Amgen Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Amgen Main Business Overview
13.3.5 Amgen Latest Developments
13.4 Shanghai Sunway
13.4.1 Shanghai Sunway Company Information
13.4.2 Shanghai Sunway Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shanghai Sunway Main Business Overview
13.4.5 Shanghai Sunway Latest Developments
13.5 Sibiono
13.5.1 Sibiono Company Information
13.5.2 Sibiono Gene Therapies for Tumor Treatment Product Portfolios and Specifications
13.5.3 Sibiono Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sibiono Main Business Overview
13.5.5 Sibiono Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapies for Tumor Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gene Therapies for Tumor Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Gene Induced Immunotherapy
Table 4. Major Players of Oncolytic Virotherapy
Table 5. Major Players of Gene Transfer
Table 6. Global Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 7. Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Table 8. Global Gene Therapies for Tumor Treatment Revenue by Type (2018-2023) & ($ million)
Table 9. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2018-2023)
Table 10. Global Gene Therapies for Tumor Treatment Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 12. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Table 13. Global Gene Therapies for Tumor Treatment Revenue by Application (2018-2023)
Table 14. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2018-2023)
Table 15. Global Gene Therapies for Tumor Treatment Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Gene Therapies for Tumor Treatment Sales by Company (2018-2023) & (K Units)
Table 17. Global Gene Therapies for Tumor Treatment Sales Market Share by Company (2018-2023)
Table 18. Global Gene Therapies for Tumor Treatment Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Gene Therapies for Tumor Treatment Revenue Market Share by Company (2018-2023)
Table 20. Global Gene Therapies for Tumor Treatment Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Gene Therapies for Tumor Treatment Producing Area Distribution and Sales Area
Table 22. Players Gene Therapies for Tumor Treatment Products Offered
Table 23. Gene Therapies for Tumor Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gene Therapies for Tumor Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Gene Therapies for Tumor Treatment Sales Market Share Geographic Region (2018-2023)
Table 28. Global Gene Therapies for Tumor Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Gene Therapies for Tumor Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Gene Therapies for Tumor Treatment Sales Market Share by Country/Region (2018-2023)
Table 32. Global Gene Therapies for Tumor Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Gene Therapies for Tumor Treatment Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Gene Therapies for Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 35. Americas Gene Therapies for Tumor Treatment Sales Market Share by Country (2018-2023)
Table 36. Americas Gene Therapies for Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Gene Therapies for Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 38. Americas Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 39. Americas Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 40. APAC Gene Therapies for Tumor Treatment Sales by Region (2018-2023) & (K Units)
Table 41. APAC Gene Therapies for Tumor Treatment Sales Market Share by Region (2018-2023)
Table 42. APAC Gene Therapies for Tumor Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Gene Therapies for Tumor Treatment Revenue Market Share by Region (2018-2023)
Table 44. APAC Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 45. APAC Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 46. Europe Gene Therapies for Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country (2018-2023)
Table 48. Europe Gene Therapies for Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 50. Europe Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 51. Europe Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Gene Therapies for Tumor Treatment
Table 59. Key Market Challenges & Risks of Gene Therapies for Tumor Treatment
Table 60. Key Industry Trends of Gene Therapies for Tumor Treatment
Table 61. Gene Therapies for Tumor Treatment Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gene Therapies for Tumor Treatment Distributors List
Table 64. Gene Therapies for Tumor Treatment Customer List
Table 65. Global Gene Therapies for Tumor Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Gene Therapies for Tumor Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Gene Therapies for Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Gene Therapies for Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Gene Therapies for Tumor Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Gene Therapies for Tumor Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Gene Therapies for Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Gene Therapies for Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Gene Therapies for Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Gene Therapies for Tumor Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Gene Therapies for Tumor Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Gene Therapies for Tumor Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Gene Therapies for Tumor Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 81. Novartis Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Kite Pharma Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Kite Pharma Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 86. Kite Pharma Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Kite Pharma Main Business
Table 88. Kite Pharma Latest Developments
Table 89. Amgen Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. Amgen Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 91. Amgen Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Amgen Main Business
Table 93. Amgen Latest Developments
Table 94. Shanghai Sunway Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Shanghai Sunway Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 96. Shanghai Sunway Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Shanghai Sunway Main Business
Table 98. Shanghai Sunway Latest Developments
Table 99. Sibiono Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Sibiono Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 101. Sibiono Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Sibiono Main Business
Table 103. Sibiono Latest Developments
Table 1. Gene Therapies for Tumor Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gene Therapies for Tumor Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Gene Induced Immunotherapy
Table 4. Major Players of Oncolytic Virotherapy
Table 5. Major Players of Gene Transfer
Table 6. Global Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 7. Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Table 8. Global Gene Therapies for Tumor Treatment Revenue by Type (2018-2023) & ($ million)
Table 9. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2018-2023)
Table 10. Global Gene Therapies for Tumor Treatment Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 12. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Table 13. Global Gene Therapies for Tumor Treatment Revenue by Application (2018-2023)
Table 14. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2018-2023)
Table 15. Global Gene Therapies for Tumor Treatment Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Gene Therapies for Tumor Treatment Sales by Company (2018-2023) & (K Units)
Table 17. Global Gene Therapies for Tumor Treatment Sales Market Share by Company (2018-2023)
Table 18. Global Gene Therapies for Tumor Treatment Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Gene Therapies for Tumor Treatment Revenue Market Share by Company (2018-2023)
Table 20. Global Gene Therapies for Tumor Treatment Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Gene Therapies for Tumor Treatment Producing Area Distribution and Sales Area
Table 22. Players Gene Therapies for Tumor Treatment Products Offered
Table 23. Gene Therapies for Tumor Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gene Therapies for Tumor Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Gene Therapies for Tumor Treatment Sales Market Share Geographic Region (2018-2023)
Table 28. Global Gene Therapies for Tumor Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Gene Therapies for Tumor Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Gene Therapies for Tumor Treatment Sales Market Share by Country/Region (2018-2023)
Table 32. Global Gene Therapies for Tumor Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Gene Therapies for Tumor Treatment Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Gene Therapies for Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 35. Americas Gene Therapies for Tumor Treatment Sales Market Share by Country (2018-2023)
Table 36. Americas Gene Therapies for Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Gene Therapies for Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 38. Americas Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 39. Americas Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 40. APAC Gene Therapies for Tumor Treatment Sales by Region (2018-2023) & (K Units)
Table 41. APAC Gene Therapies for Tumor Treatment Sales Market Share by Region (2018-2023)
Table 42. APAC Gene Therapies for Tumor Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Gene Therapies for Tumor Treatment Revenue Market Share by Region (2018-2023)
Table 44. APAC Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 45. APAC Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 46. Europe Gene Therapies for Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country (2018-2023)
Table 48. Europe Gene Therapies for Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 50. Europe Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 51. Europe Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Gene Therapies for Tumor Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Gene Therapies for Tumor Treatment Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Gene Therapies for Tumor Treatment
Table 59. Key Market Challenges & Risks of Gene Therapies for Tumor Treatment
Table 60. Key Industry Trends of Gene Therapies for Tumor Treatment
Table 61. Gene Therapies for Tumor Treatment Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gene Therapies for Tumor Treatment Distributors List
Table 64. Gene Therapies for Tumor Treatment Customer List
Table 65. Global Gene Therapies for Tumor Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Gene Therapies for Tumor Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Gene Therapies for Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Gene Therapies for Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Gene Therapies for Tumor Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Gene Therapies for Tumor Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Gene Therapies for Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Gene Therapies for Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Gene Therapies for Tumor Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Gene Therapies for Tumor Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Gene Therapies for Tumor Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Gene Therapies for Tumor Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Gene Therapies for Tumor Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Novartis Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 81. Novartis Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Kite Pharma Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Kite Pharma Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 86. Kite Pharma Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Kite Pharma Main Business
Table 88. Kite Pharma Latest Developments
Table 89. Amgen Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. Amgen Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 91. Amgen Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Amgen Main Business
Table 93. Amgen Latest Developments
Table 94. Shanghai Sunway Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Shanghai Sunway Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 96. Shanghai Sunway Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Shanghai Sunway Main Business
Table 98. Shanghai Sunway Latest Developments
Table 99. Sibiono Basic Information, Gene Therapies for Tumor Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Sibiono Gene Therapies for Tumor Treatment Product Portfolios and Specifications
Table 101. Sibiono Gene Therapies for Tumor Treatment Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Sibiono Main Business
Table 103. Sibiono Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gene Therapies for Tumor Treatment
Figure 2. Gene Therapies for Tumor Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gene Therapies for Tumor Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gene Therapies for Tumor Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gene Therapies for Tumor Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Gene Induced Immunotherapy
Figure 10. Product Picture of Oncolytic Virotherapy
Figure 11. Product Picture of Gene Transfer
Figure 12. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2022
Figure 13. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2018-2023)
Figure 14. Gene Therapies for Tumor Treatment Consumed in Hospital
Figure 15. Global Gene Therapies for Tumor Treatment Market: Hospital (2018-2023) & (K Units)
Figure 16. Gene Therapies for Tumor Treatment Consumed in Clinic
Figure 17. Global Gene Therapies for Tumor Treatment Market: Clinic (2018-2023) & (K Units)
Figure 18. Gene Therapies for Tumor Treatment Consumed in Other
Figure 19. Global Gene Therapies for Tumor Treatment Market: Other (2018-2023) & (K Units)
Figure 20. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2022)
Figure 21. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application in 2022
Figure 22. Gene Therapies for Tumor Treatment Sales Market by Company in 2022 (K Units)
Figure 23. Global Gene Therapies for Tumor Treatment Sales Market Share by Company in 2022
Figure 24. Gene Therapies for Tumor Treatment Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Gene Therapies for Tumor Treatment Revenue Market Share by Company in 2022
Figure 26. Global Gene Therapies for Tumor Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Gene Therapies for Tumor Treatment Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 29. Americas Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 30. APAC Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 31. APAC Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 32. Europe Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 33. Europe Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 36. Americas Gene Therapies for Tumor Treatment Sales Market Share by Country in 2022
Figure 37. Americas Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2022
Figure 38. Americas Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 39. Americas Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 40. United States Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Gene Therapies for Tumor Treatment Sales Market Share by Region in 2022
Figure 45. APAC Gene Therapies for Tumor Treatment Revenue Market Share by Regions in 2022
Figure 46. APAC Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 47. APAC Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 48. China Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country in 2022
Figure 56. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2022
Figure 57. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 58. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 59. Germany Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 68. Egypt Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Gene Therapies for Tumor Treatment in 2022
Figure 74. Manufacturing Process Analysis of Gene Therapies for Tumor Treatment
Figure 75. Industry Chain Structure of Gene Therapies for Tumor Treatment
Figure 76. Channels of Distribution
Figure 77. Global Gene Therapies for Tumor Treatment Sales Market Forecast by Region (2024-2029)
Figure 78. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Gene Therapies for Tumor Treatment
Figure 2. Gene Therapies for Tumor Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gene Therapies for Tumor Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gene Therapies for Tumor Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gene Therapies for Tumor Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Gene Induced Immunotherapy
Figure 10. Product Picture of Oncolytic Virotherapy
Figure 11. Product Picture of Gene Transfer
Figure 12. Global Gene Therapies for Tumor Treatment Sales Market Share by Type in 2022
Figure 13. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2018-2023)
Figure 14. Gene Therapies for Tumor Treatment Consumed in Hospital
Figure 15. Global Gene Therapies for Tumor Treatment Market: Hospital (2018-2023) & (K Units)
Figure 16. Gene Therapies for Tumor Treatment Consumed in Clinic
Figure 17. Global Gene Therapies for Tumor Treatment Market: Clinic (2018-2023) & (K Units)
Figure 18. Gene Therapies for Tumor Treatment Consumed in Other
Figure 19. Global Gene Therapies for Tumor Treatment Market: Other (2018-2023) & (K Units)
Figure 20. Global Gene Therapies for Tumor Treatment Sales Market Share by Application (2022)
Figure 21. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application in 2022
Figure 22. Gene Therapies for Tumor Treatment Sales Market by Company in 2022 (K Units)
Figure 23. Global Gene Therapies for Tumor Treatment Sales Market Share by Company in 2022
Figure 24. Gene Therapies for Tumor Treatment Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Gene Therapies for Tumor Treatment Revenue Market Share by Company in 2022
Figure 26. Global Gene Therapies for Tumor Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Gene Therapies for Tumor Treatment Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 29. Americas Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 30. APAC Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 31. APAC Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 32. Europe Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 33. Europe Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Gene Therapies for Tumor Treatment Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Gene Therapies for Tumor Treatment Revenue 2018-2023 ($ Millions)
Figure 36. Americas Gene Therapies for Tumor Treatment Sales Market Share by Country in 2022
Figure 37. Americas Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2022
Figure 38. Americas Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 39. Americas Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 40. United States Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Gene Therapies for Tumor Treatment Sales Market Share by Region in 2022
Figure 45. APAC Gene Therapies for Tumor Treatment Revenue Market Share by Regions in 2022
Figure 46. APAC Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 47. APAC Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 48. China Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Gene Therapies for Tumor Treatment Sales Market Share by Country in 2022
Figure 56. Europe Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2022
Figure 57. Europe Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 58. Europe Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 59. Germany Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Gene Therapies for Tumor Treatment Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share by Application (2018-2023)
Figure 68. Egypt Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Gene Therapies for Tumor Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Gene Therapies for Tumor Treatment in 2022
Figure 74. Manufacturing Process Analysis of Gene Therapies for Tumor Treatment
Figure 75. Industry Chain Structure of Gene Therapies for Tumor Treatment
Figure 76. Channels of Distribution
Figure 77. Global Gene Therapies for Tumor Treatment Sales Market Forecast by Region (2024-2029)
Figure 78. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Gene Therapies for Tumor Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Gene Therapies for Tumor Treatment Revenue Market Share Forecast by Application (2024-2029)
